-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.0060% Upside
NRx Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover NRx Pharmaceuticals, Inc.?
NRx Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.